Los Angeles Capital Management’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23,123
| Closed | -$226K | – | 1438 |
|
|
2025
Q1 | $226K | Sell |
23,123
-4,377
| -16% | -$42.7K | ﹤0.01% | 977 |
|
|
2024
Q4 | $348K | Buy |
27,500
+2,320
| +9% | +$29.3K | ﹤0.01% | 898 |
|
|
2024
Q3 | $405K | Buy |
25,180
+14,607
| +138% | +$235K | ﹤0.01% | 920 |
|
|
2024
Q2 | $258K | Buy |
10,573
+4,211
| +66% | +$103K | ﹤0.01% | 1063 |
|
|
2024
Q1 | $457K | Buy |
6,362
+5,190
| +443% | +$373K | ﹤0.01% | 899 |
|
|
2023
Q4 | $233K | Buy |
+1,172
| New | +$233K | ﹤0.01% | 1072 |
|
|
2023
Q3 | – | Sell |
-3,594
| Closed | -$538K | – | 1216 |
|
|
2023
Q2 | $538K | Sell |
3,594
-7,828
| -69% | -$1.17M | ﹤0.01% | 831 |
|
|
2023
Q1 | $1.68M | Sell |
11,422
-3,716
| -25% | -$545K | 0.01% | 539 |
|
|
2022
Q4 | $2.4M | Buy |
15,138
+13,626
| +901% | +$2.16M | 0.01% | 474 |
|
|
2022
Q3 | $291K | Buy |
+1,512
| New | +$291K | ﹤0.01% | 1076 |
|
|
2022
Q1 | – | Sell |
-1,322
| Closed | -$388K | – | 1480 |
|
|
2021
Q4 | $388K | Hold |
1,322
| – | – | ﹤0.01% | 1126 |
|
|
2021
Q3 | $328K | Sell |
1,322
-972
| -42% | -$241K | ﹤0.01% | 1267 |
|
|
2021
Q2 | $583K | Buy |
2,294
+99
| +5% | +$25.2K | ﹤0.01% | 1109 |
|
|
2021
Q1 | $390K | Buy |
+2,195
| New | +$390K | ﹤0.01% | 1329 |
|